Clinical Trial

A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Orthopedic Surgery

Completed Phase 2
View on ClinicalTrials.gov →
Summary
The primary objective is to evaluate the analgesic efficacy and safety of IV YZJ-4729 Tartrate Injection in patients with acute postoperative pain following Orthopedic surgery
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-24.
Status change: Not Yet Recruiting → Completed 2026-06-26
Trial Details
NCT Number NCT06901830
Lead Sponsor Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Conditions Pain
Enrollment 150 participants
Start Date 2025-05-23
Primary Completion 2025-12-06 (estimated)
Study Completion 2025-12-18 (estimated)
Updated on ClinicalTrials.gov 2026-06-29